These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers' diarrhoea in a randomised, double-blind, placebo-controlled study. Leyten EM, Soonawala D, Schultsz C, Herzog C, Ligthelm RJ, Wijnands S, Visser LG. Vaccine; 2005 Oct 17; 23(43):5120-6. PubMed ID: 15982790 [Abstract] [Full Text] [Related]
4. Prevention of fecal-orally transmitted diseases in travelers through an oral anticholeric vaccine (WC/rBS). Gabutti G, Aquilina M, Cova M, Giuffrida S, Lizioli A, Protano D, Scrivano F, Tomasi A, Cucchi A, Cavallaro A, Collaborative Group for the Study of Fecal-Orally Transmitted Diseases in Travelers. J Prev Med Hyg; 2012 Dec 17; 53(4):199-203. PubMed ID: 23469588 [Abstract] [Full Text] [Related]
7. Oral cholera vaccines: use in clinical practice. Hill DR, Ford L, Lalloo DG. Lancet Infect Dis; 2006 Jun 17; 6(6):361-73. PubMed ID: 16728322 [Abstract] [Full Text] [Related]
8. Cost-benefit of WC/rBS oral cholera vaccine for vaccination against ETEC-caused travelers' diarrhea. Lundkvist J, Steffen R, Jönsson B. J Travel Med; 2009 Jun 17; 16(1):28-34. PubMed ID: 19192125 [Abstract] [Full Text] [Related]
9. Statement on new oral cholera and travellers' diarrhea vaccination. Committee to Advise on Tropical Medicine and Travel (CATMAT), National Advisory Committee on Immunization (NACI). Can Commun Dis Rep; 2005 Jul 01; 31(ACS-7):1-11. PubMed ID: 15999424 [No Abstract] [Full Text] [Related]
11. Effectiveness and economic analysis of the whole cell/recombinant B subunit (WC/rbs) inactivated oral cholera vaccine in the prevention of traveller's diarrhoea. López-Gigosos R, Garcia-Fortea P, Calvo MJ, Reina E, Diez-Diaz R, Plaza E. BMC Infect Dis; 2009 May 16; 9():65. PubMed ID: 19445712 [Abstract] [Full Text] [Related]
12. Vaccination with Dukoral against travelers' diarrhea (ETEC) and cholera. Jelinek T, Kollaritsch H. Expert Rev Vaccines; 2008 Jul 16; 7(5):561-7. PubMed ID: 18564011 [Abstract] [Full Text] [Related]
13. [Prophylactic immunization against enterotoxin-forming Escherichia coli travellers' diarrhea and cholera: does it make sense and for whom?]. Weinke T, Liebold I, Burchard GD, Frühwein N, Grobusch MP, Hatz C, Kollaritsch H, Nothdurft HD, Reisinger E, Rieke B, Schönfeld Ch, Steffen R, Stich A. Dtsch Med Wochenschr; 2006 Jul 28; 131(30):1660-4. PubMed ID: 16850383 [No Abstract] [Full Text] [Related]
15. Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine. Peltola H, Siitonen A, Kyrönseppä H, Simula I, Mattila L, Oksanen P, Kataja MJ, Cadoz M. Lancet; 1991 Nov 23; 338(8778):1285-9. PubMed ID: 1682684 [Abstract] [Full Text] [Related]
16. Development of vaccines against cholera and diarrhoea due to enterotoxigenic Escherichia coli: memorandum from a WHO meeting. Bull World Health Organ; 1990 Nov 23; 68(3):303-12. PubMed ID: 2203550 [Abstract] [Full Text] [Related]
19. [Traveller's diarrhea: which vaccines?]. Ivanoff B. Bull Soc Pathol Exot; 1998 Nov 23; 91(5 Pt 1-2):456-60. PubMed ID: 10078386 [Abstract] [Full Text] [Related]
20. Effectiveness of mass oral cholera vaccination in Beira, Mozambique. Lucas ME, Deen JL, von Seidlein L, Wang XY, Ampuero J, Puri M, Ali M, Ansaruzzaman M, Amos J, Macuamule A, Cavailler P, Guerin PJ, Mahoudeau C, Kahozi-Sangwa P, Chaignat CL, Barreto A, Songane FF, Clemens JD. N Engl J Med; 2005 Feb 24; 352(8):757-67. PubMed ID: 15728808 [Abstract] [Full Text] [Related] Page: [Next] [New Search]